Jennifer Dominguez
Medical · Naples, FLNPI 1588036347
Payments from drug & device makers
Across 116 payments — averaging $25.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$628
- Teva Pharmaceuticals USA, Inc.$516
- Collegium Pharmaceutical, Inc.$237
- Boston Scientific$223
- Biohaven Pharmaceuticals, Inc.$204
- Arthrex$145
- plus $969 from 19 others
What the payments were for
- Food & beverage$2,81996%
- Education$1034%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $628 |
| Teva Pharmaceuticals USA, Inc. | 19 | $516 |
| Collegium Pharmaceutical, Inc. | 10 | $237 |
| Boston Scientific | 10 | $223 |
| Biohaven Pharmaceuticals, Inc. | 7 | $204 |
| Arthrex | 2 | $145 |
| Pfizer | 3 | $136 |
| Scilex Pharmaceuticals Inc. | 6 | $119 |
| Nevro Corp. | 4 | $101 |
| Si-bone, Inc. | 3 | $89 |
| Lundbeck LLC | 1 | $73 |
| Almatica Pharma LLC | 4 | $62 |
| Redhill Biopharma Inc. | 3 | $48 |
| Abbott | 2 | $46 |
| Medtronic | 2 | $44 |
| Amgen | 2 | $38 |
| Fidia Pharma USA Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $28 |
| Pacira Therapeutics, Inc. | 1 | $28 |
| GRT US Holding, Inc. | 1 | $27 |
| Globus Medical | 1 | $26 |
| Eagle Pharmaceuticals, Inc. | 1 | $24 |
| Novartis | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$141
- Austedo XR$125
- NURTEC ODT$112
How this compares
$2,922 in reported general payments places this provider in the 75th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 569 | $6,926 |
| Buprenorphine | 15 | $4,714 |
| Tramadol Hcl | 165 | $1,595 |
| Pregabalin | 80 | $1,206 |
| Duloxetine Hcl | 90 | $1,165 |
| Baclofen | 72 | $795 |
| Celecoxib | 28 | $744 |
| Tramadol Hcl ErTramadol Hcl | 13 | $604 |
| Diclofenac Sodium | 15 | $577 |
| Meloxicam | 61 | $366 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 15 | $277 |
| Cyclobenzaprine Hcl | 27 | $248 |
| Methocarbamol | 31 | $230 |
| Methylprednisolone | 27 | $212 |
| Tizanidine Hcl | 29 | $197 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USABuprenorphine | $13 | $4,71415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,031 medical providers in Florida.
Other medical in Naples
- Shanna MirantiNaples$415K
- Yekaterina GrigolNaples$18K
- Gary RubinRockledge$2.1M
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.